FI954138A0 - Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä - Google Patents

Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä

Info

Publication number
FI954138A0
FI954138A0 FI954138A FI954138A FI954138A0 FI 954138 A0 FI954138 A0 FI 954138A0 FI 954138 A FI954138 A FI 954138A FI 954138 A FI954138 A FI 954138A FI 954138 A0 FI954138 A0 FI 954138A0
Authority
FI
Finland
Prior art keywords
acid derivatives
treatment
cardiovascular diseases
hydroxymethylfurazanecarboxylic
hydroxymethylfurazanecarboxylic acid
Prior art date
Application number
FI954138A
Other languages
English (en)
Swedish (sv)
Other versions
FI954138A (fi
Inventor
Karl Schoenafinger
Helmut Bohn
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI954138A publication Critical patent/FI954138A/fi
Publication of FI954138A0 publication Critical patent/FI954138A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI954138A 1993-03-06 1995-09-04 Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä FI954138A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4307105A DE4307105A1 (de) 1993-03-06 1993-03-06 Hydroxymethylfurazancarbonsäurederivate
PCT/EP1994/000459 WO1994020478A1 (de) 1993-03-06 1994-02-18 Hydroxymethylfurazancarbonsäurederivate und ihre verwendung in der behandlung von kardiovaskulären erkrankungen

Publications (2)

Publication Number Publication Date
FI954138A FI954138A (fi) 1995-09-04
FI954138A0 true FI954138A0 (fi) 1995-09-04

Family

ID=6482135

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954138A FI954138A0 (fi) 1993-03-06 1995-09-04 Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä

Country Status (21)

Country Link
US (1) US5486531A (fi)
EP (1) EP0687256B1 (fi)
JP (1) JP3578456B2 (fi)
KR (1) KR960701029A (fi)
CN (1) CN1043140C (fi)
AT (1) ATE157660T1 (fi)
AU (1) AU676718B2 (fi)
CA (1) CA2155840C (fi)
CZ (1) CZ284264B6 (fi)
DE (2) DE4307105A1 (fi)
DK (1) DK0687256T3 (fi)
ES (1) ES2108977T3 (fi)
FI (1) FI954138A0 (fi)
GR (1) GR3024928T3 (fi)
HU (1) HUT72641A (fi)
IL (1) IL108856A (fi)
PL (1) PL177603B1 (fi)
RU (1) RU2134687C1 (fi)
SK (1) SK280354B6 (fi)
WO (1) WO1994020478A1 (fi)
ZA (1) ZA941533B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4401150A1 (de) * 1994-01-17 1995-07-20 Cassella Ag Furazancarbonsäurederivate
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US7385061B2 (en) * 2003-05-23 2008-06-10 Basilea Pharmaceutica Ag Furazanobenzimidazoles
US8822509B2 (en) 2006-12-29 2014-09-02 The University Of Queensland Pain-relieving compositions and uses therefor
CN112125865B (zh) * 2020-09-30 2022-08-12 北京理工大学 氧化呋咱化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3012862A1 (de) * 1980-04-02 1981-10-08 Cassella Ag, 6000 Frankfurt Substituierte 1,2,5-oxdiazol-2-oxide als pharmazeutische wirkstoffe, ihre verwendung und sie enthaltende arzneimittel
DE3047730A1 (de) * 1980-12-18 1982-07-15 Cassella Ag, 6000 Frankfurt 3,4-bis-substituierte 1,2,5-oxdiazol-2-oxide, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen

Also Published As

Publication number Publication date
FI954138A (fi) 1995-09-04
EP0687256A1 (de) 1995-12-20
AU676718B2 (en) 1997-03-20
AU6141494A (en) 1994-09-26
CZ228195A3 (en) 1995-12-13
JP3578456B2 (ja) 2004-10-20
ATE157660T1 (de) 1997-09-15
CA2155840C (en) 2005-05-24
PL177603B1 (pl) 1999-12-31
SK110095A3 (en) 1996-01-10
HU9502603D0 (en) 1995-11-28
DK0687256T3 (da) 1998-03-30
PL310655A1 (en) 1995-12-27
EP0687256B1 (de) 1997-09-03
GR3024928T3 (en) 1998-01-30
IL108856A (en) 1997-07-13
CN1119013A (zh) 1996-03-20
SK280354B6 (sk) 1999-12-10
CZ284264B6 (cs) 1998-10-14
DE4307105A1 (de) 1994-09-08
JPH08507299A (ja) 1996-08-06
ES2108977T3 (es) 1998-01-01
DE59403966D1 (de) 1997-10-09
WO1994020478A1 (de) 1994-09-15
ZA941533B (en) 1994-10-06
IL108856A0 (en) 1994-06-24
US5486531A (en) 1996-01-23
RU2134687C1 (ru) 1999-08-20
CA2155840A1 (en) 1994-09-15
CN1043140C (zh) 1999-04-28
HUT72641A (en) 1996-05-28
KR960701029A (ko) 1996-02-24

Similar Documents

Publication Publication Date Title
GR78945B (fi)
ES2134926T3 (es) Derivados vinileno-azaindolicos y su procedimiento de preparacion.
DE122006000010I1 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3- Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten
TR199901905T2 (xx) 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
ES2105362T3 (es) Nuevos derivados de acidos quinolon- y naftiridoncarboxilicos.
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
NO944946L (no) Forgrenet-amino-substituerte tiazoler, fremgangsmåter for fremstilling av dem og farmasöytiske blandinger inneholdende dem
FI954138A0 (fi) Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä
DE69418744D1 (de) Verwendung von Pregnanderivaten zur Behandlung von Tumoren
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
NO175745C (no) Analogifremgangsmåte for fremstilling av dibenzo(1,5)-dioksocin-5-oner
FR2446279A1 (fr) Cis- et trans-3-aryloxy-4-hydroxypyrrolidines et leurs derives, utiles notamment en medecine veterinaire comme antidepresseurs
ATE158576T1 (de) Alpha-aryl-alpha-hydroxy-beta- imidazolinylpropionsäureamide
NO960271D0 (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
DE69409799D1 (de) Herstellung von symmetrischen und unsymmetrischen disubstituierten n-cyandithioiminocarbonaten
ATE168683T1 (de) Substituierte iminoacetonitrile mit myokardprotektiver wirkung